Selected research
Market Outlook & Growth Opportunities
Global Hexacosanol Market Outlook and Growth Opportunities 2026
Market perspective
The global Hexacosanol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Hexacosanol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Hexacosanol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hexacosanol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Hexacosanol market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Hexacosanol market include AMBE PHYTOEXTRACTS, Charkit Chemical Company, Herblink Biotech, Xian Pincredit Bio-Tech, Huzhou Shengtao Biotech, Deqing Weikangshengwu and Nutritopper biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Hexacosanol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Hexacosanol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Hexacosanol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hexacosanol market size, projected growth trends, production technologies, key applications, and end-use industries.
Hexacosanol Segment by Company
AMBE PHYTOEXTRACTS
Charkit Chemical Company
Herblink Biotech
Xian Pincredit Bio-Tech
Huzhou Shengtao Biotech
Deqing Weikangshengwu
Nutritopper biotechnology
Hexacosanol Segment by Type
Purity 98%
Purity 99%
Hexacosanol Segment by Application
Medicine
Food Supplement
Other
Hexacosanol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Hexacosanol status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Hexacosanol market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Hexacosanol significant trends, drivers, influence factors in global and regions.
6. To analyze Hexacosanol competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hexacosanol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hexacosanol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hexacosanol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Hexacosanol market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hexacosanol industry.
Chapter 3: Detailed analysis of Hexacosanol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Hexacosanol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Hexacosanol in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 98%
- Purity 99%
Applications
- Medicine
- Food Supplement
- Other
Companies covered
- AMBE PHYTOEXTRACTS
- Charkit Chemical Company
- Herblink Biotech
- Xian Pincredit Bio-Tech
- Huzhou Shengtao Biotech
- Deqing Weikangshengwu
- Nutritopper biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Hexacosanol Sales Value (2021-2032)
- 1.2.2 Global Hexacosanol Sales Volume (2021-2032)
- 1.2.3 Global Hexacosanol Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Hexacosanol Market Dynamics
- 2.1 Hexacosanol Industry Trends
- 2.2 Hexacosanol Industry Drivers
- 2.3 Hexacosanol Industry Opportunities and Challenges
- 2.4 Hexacosanol Industry Restraints
3 Hexacosanol Market by Company
- 3.1 Global Hexacosanol Company Revenue Ranking in 2025
- 3.2 Global Hexacosanol Revenue by Company (2021-2026)
- 3.3 Global Hexacosanol Sales Volume by Company (2021-2026)
- 3.4 Global Hexacosanol Average Price by Company (2021-2026)
- 3.5 Global Hexacosanol Company Ranking (2024-2026)
- 3.6 Global Hexacosanol Company Manufacturing Base and Headquarters
- 3.7 Global Hexacosanol Company Product Type and Application
- 3.8 Global Hexacosanol Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Hexacosanol Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Hexacosanol Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Hexacosanol Market by Type
- 4.1 Hexacosanol Type Introduction
- 4.1.1 Purity 98%
- 4.1.2 Purity 99%
- 4.2 Global Hexacosanol Sales Volume by Type
- 4.2.1 Global Hexacosanol Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Hexacosanol Sales Volume by Type (2021-2032)
- 4.2.3 Global Hexacosanol Sales Volume Share by Type (2021-2032)
- 4.3 Global Hexacosanol Sales Value by Type
- 4.3.1 Global Hexacosanol Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Hexacosanol Sales Value by Type (2021-2032)
- 4.3.3 Global Hexacosanol Sales Value Share by Type (2021-2032)
5 Hexacosanol Market by Application
- 5.1 Hexacosanol Application Introduction
- 5.1.1 Medicine
- 5.1.2 Food Supplement
- 5.1.3 Other
- 5.2 Global Hexacosanol Sales Volume by Application
- 5.2.1 Global Hexacosanol Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Hexacosanol Sales Volume by Application (2021-2032)
- 5.2.3 Global Hexacosanol Sales Volume Share by Application (2021-2032)
- 5.3 Global Hexacosanol Sales Value by Application
- 5.3.1 Global Hexacosanol Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Hexacosanol Sales Value by Application (2021-2032)
- 5.3.3 Global Hexacosanol Sales Value Share by Application (2021-2032)
6 Hexacosanol Regional Sales and Value Analysis
- 6.1 Global Hexacosanol Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Hexacosanol Sales by Region (2021-2032)
- 6.2.1 Global Hexacosanol Sales by Region: 2021-2026
- 6.2.2 Global Hexacosanol Sales by Region (2027-2032)
- 6.3 Global Hexacosanol Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Hexacosanol Sales Value by Region (2021-2032)
- 6.4.1 Global Hexacosanol Sales Value by Region: 2021-2026
- 6.4.2 Global Hexacosanol Sales Value by Region (2027-2032)
- 6.5 Global Hexacosanol Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Hexacosanol Sales Value (2021-2032)
- 6.6.2 North America Hexacosanol Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Hexacosanol Sales Value (2021-2032)
- 6.7.2 Europe Hexacosanol Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Hexacosanol Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Hexacosanol Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Hexacosanol Sales Value (2021-2032)
- 6.9.2 South America Hexacosanol Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Hexacosanol Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Hexacosanol Sales Value Share by Country, 2025 VS 2032
7 Hexacosanol Country-level Sales and Value Analysis
- 7.1 Global Hexacosanol Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Hexacosanol Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Hexacosanol Sales by Country (2021-2032)
- 7.3.1 Global Hexacosanol Sales by Country (2021-2026)
- 7.3.2 Global Hexacosanol Sales by Country (2027-2032)
- 7.4 Global Hexacosanol Sales Value by Country (2021-2032)
- 7.4.1 Global Hexacosanol Sales Value by Country (2021-2026)
- 7.4.2 Global Hexacosanol Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.9.2 France Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.16.2 China Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.19.2 India Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Hexacosanol Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Hexacosanol Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Hexacosanol Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Hexacosanol Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 AMBE PHYTOEXTRACTS
- 8.1.1 AMBE PHYTOEXTRACTS Company Information
- 8.1.2 AMBE PHYTOEXTRACTS Business Overview
- 8.1.3 AMBE PHYTOEXTRACTS Hexacosanol Sales, Value and Gross Margin (2021-2026)
- 8.1.4 AMBE PHYTOEXTRACTS Hexacosanol Product Portfolio
- 8.1.5 AMBE PHYTOEXTRACTS Recent Developments
- 8.2 Charkit Chemical Company
- 8.2.1 Charkit Chemical Company Company Information
- 8.2.2 Charkit Chemical Company Business Overview
- 8.2.3 Charkit Chemical Company Hexacosanol Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Charkit Chemical Company Hexacosanol Product Portfolio
- 8.2.5 Charkit Chemical Company Recent Developments
- 8.3 Herblink Biotech
- 8.3.1 Herblink Biotech Company Information
- 8.3.2 Herblink Biotech Business Overview
- 8.3.3 Herblink Biotech Hexacosanol Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Herblink Biotech Hexacosanol Product Portfolio
- 8.3.5 Herblink Biotech Recent Developments
- 8.4 Xian Pincredit Bio-Tech
- 8.4.1 Xian Pincredit Bio-Tech Company Information
- 8.4.2 Xian Pincredit Bio-Tech Business Overview
- 8.4.3 Xian Pincredit Bio-Tech Hexacosanol Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Xian Pincredit Bio-Tech Hexacosanol Product Portfolio
- 8.4.5 Xian Pincredit Bio-Tech Recent Developments
- 8.5 Huzhou Shengtao Biotech
- 8.5.1 Huzhou Shengtao Biotech Company Information
- 8.5.2 Huzhou Shengtao Biotech Business Overview
- 8.5.3 Huzhou Shengtao Biotech Hexacosanol Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Huzhou Shengtao Biotech Hexacosanol Product Portfolio
- 8.5.5 Huzhou Shengtao Biotech Recent Developments
- 8.6 Deqing Weikangshengwu
- 8.6.1 Deqing Weikangshengwu Company Information
- 8.6.2 Deqing Weikangshengwu Business Overview
- 8.6.3 Deqing Weikangshengwu Hexacosanol Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Deqing Weikangshengwu Hexacosanol Product Portfolio
- 8.6.5 Deqing Weikangshengwu Recent Developments
- 8.7 Nutritopper biotechnology
- 8.7.1 Nutritopper biotechnology Company Information
- 8.7.2 Nutritopper biotechnology Business Overview
- 8.7.3 Nutritopper biotechnology Hexacosanol Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Nutritopper biotechnology Hexacosanol Product Portfolio
- 8.7.5 Nutritopper biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Hexacosanol Value Chain Analysis
- 9.1.1 Hexacosanol Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Hexacosanol Sales Mode & Process
- 9.2 Hexacosanol Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Hexacosanol Distributors
- 9.2.3 Hexacosanol Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst